| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/04/2006 | EP1129079B1 2,4-disubstituded triazine derivatives with anti hiv activity |
| 01/04/2006 | EP1083898B1 Novel use of hiv protease inhibiting compounds |
| 01/04/2006 | EP1064004B1 Metal/thiol biocides |
| 01/04/2006 | EP0927255B1 Vaccine production of the bacillus anthracis protective antigen |
| 01/04/2006 | CN1717494A Beta-1,4-mannobiose-containing composition |
| 01/04/2006 | CN1717417A Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases |
| 01/04/2006 | CN1717246A Method for producing a biologically active substance |
| 01/04/2006 | CN1717239A Transdermal therapeutic system containing testosterone and method for the production thereof |
| 01/04/2006 | CN1717231A Lysine mixture and apparatus and method for administering lysine |
| 01/04/2006 | CN1717227A Pharmaceutical compositions comprising flavonoids and menthol |
| 01/04/2006 | CN1715296A Recombinant human mannan-binding lectin |
| 01/04/2006 | CN1715291A Synthesis of oleanolic acid succinic acid monoester and its medicinal preparation for treating chronic and acute hepatitis |
| 01/04/2006 | CN1715289A Process for preparing 4 -substituted-9-deoxo-9a-aza-9a-homoerythromycin A derivatives |
| 01/04/2006 | CN1715269A Cyanopyrrolidine derivatives |
| 01/04/2006 | CN1714869A Anhydrous topical skin preparations |
| 01/04/2006 | CN1714861A Thymus penta peptide slow releasing micro ball and its preparing method |
| 01/04/2006 | CN1714860A Chinese medicine composition for dissolving stone, anti-inflammation, analgesia and bacteriostat and its preparing method |
| 01/04/2006 | CN1714848A Medicine for treating smelly foot and its preparing method |
| 01/04/2006 | CN1714842A Chinese medicine composition for smoothing liver-gallbladder and clearing heat and detoxicating and its preparing method |
| 01/04/2006 | CN1714834A Medicine for treating hepatitis B hepatitis C, hepatitis cirrhosis |
| 01/04/2006 | CN1714815A Bee glue and saussurea involucrata wine |
| 01/04/2006 | CN1714813A Chinese medicine preparation for preventing and treating beri-beri |
| 01/04/2006 | CN1714810A Drugs, foods, drinks and feeds containing cocoa component |
| 01/04/2006 | CN1714809A Drugs, foods, drinks and feeds containing cocoa component |
| 01/04/2006 | CN1714803A Method for producing medicine egg for treating child lymph tuberculosis |
| 01/04/2006 | CN1714793A Famciclovir slow-releasing capsule for anti-virus treatment and its producing method |
| 01/04/2006 | CN1714790A Fibrauretine transfusion preparation and its preparing method |
| 01/04/2006 | CN1714788A Tinidazole powder injection and its preparing method |
| 01/04/2006 | CN1234718C New macrolides with antibacterial activity |
| 01/04/2006 | CN1234716C Preparation method of sulfuric acid polysaccharide kind substance 911 oligosaccharide fragment and its application |
| 01/04/2006 | CN1234711C Mikanolide derivatives,their preparation and its therapeutic uses |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234426C Topical pharmaceutical formulation |
| 01/04/2006 | CN1234412C Method for large-scale continuous production of virus vaccine |
| 01/04/2006 | CN1234408C Chinese medicine preparation for treating AIDS and preventing cancer |
| 01/04/2006 | CN1234400C Medicine for treating viral hepatitis B |
| 01/04/2006 | CN1234395C Medicinal tea for preventing and treating flu virus and SARS virus caused respiratory tract infection and its production method |
| 01/04/2006 | CN1234384C Chinese medicinal preparation for preventing and curing enteric disease of animal and poultry and its preparation method |
| 01/04/2006 | CN1234381C Medicine compositions for treating hepatitis, and its preparing method |
| 01/04/2006 | CN1234374C Ointment for treating pointed condyloma |
| 01/04/2006 | CN1234369C Bacillus prodigiosus polysaccharide for nose drops |
| 01/04/2006 | CN1234359C Use of oxidized matrine in preparation of chemicals for treating viral myocarditis |
| 01/04/2006 | CN1234355C Medicinal composition having anti-inflammation and anti-infection function |
| 01/04/2006 | CN1234347C Anti-virus composition |
| 01/04/2006 | CN1234346C Optimised formulation of tobramycin for aeroselization |
| 01/04/2006 | CN1234341C Oily cosmetics and its praration |
| 01/03/2006 | US6982335 Synthesis of substituted thiazoline carboxylic acids |
| 01/03/2006 | US6982334 Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid |
| 01/03/2006 | US6982320 Cytokine receptor common gamma chain like |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | US6982258 Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3 |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | US6982247 isolated peptide or protein of given sequence derived from the mucus of the foot sole of Archachatina marginata, a West-African snail; use against viral, bacterial or fungal infections |
| 01/03/2006 | US6982088 Vaccine composition and stabilization method using high molecular weight PVP |
| 01/03/2006 | US6982086 Human immunodeficiency virus immunogenic composition |
| 01/03/2006 | CA2264901C Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 01/03/2006 | CA2162463C Azolylamine derivative |
| 01/03/2006 | CA2158937C Recombinant alphavirus vectors |
| 01/03/2006 | CA2136622C Phosphotriester-type biologically active compounds |
| 01/03/2006 | CA2135852C 5-methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4t) |
| 01/03/2006 | CA2117651C Itraconazole and saperconazole stereoisomers |
| 12/30/2005 | CA2511084A1 Carbohydrate-phosphorylcholine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications |
| 12/29/2005 | WO2005123965A1 Potent and selective inhibition by aurintricarboxylic acid |
| 12/29/2005 | WO2005123935A1 Method of producing therapeutically useful product and system |
| 12/29/2005 | WO2005123645A1 Regulators of bacterial signalling pathways |
| 12/29/2005 | WO2005123124A1 Q fever vaccine preparation and method of producing the vaccine |
| 12/29/2005 | WO2005123120A1 Sustained release vaccine composition |
| 12/29/2005 | WO2005123100A1 Lactic bacteria and their use in the prevention of diarrhea |
| 12/29/2005 | WO2005123065A1 Chemokine receptor antagonistic medicinal composition |
| 12/29/2005 | WO2005123057A1 Antimicrobial compositions and methods of use thereof |
| 12/29/2005 | WO2005062882A3 Rifamycin analogs and uses thereof |
| 12/29/2005 | WO2004094599A3 Disease prevention and vaccination following thymic reactivation |
| 12/29/2005 | WO2004069166A3 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288368 Compositions and methods for treating and preventing necrosis |
| 12/29/2005 | US20050288356 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 12/29/2005 | US20050288349 Cancer treatments and pharmaceutical compositions therefor |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288324 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
| 12/29/2005 | US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates |
| 12/29/2005 | US20050288307 Anti-viral compounds |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 12/29/2005 | US20050288293 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 12/29/2005 | US20050288278 HIV replication inhibiting pyrimidines |
| 12/29/2005 | US20050288273 Antibacterial agents |
| 12/29/2005 | US20050288261 Compositions and method for treating infection in cattle and swine |
| 12/29/2005 | US20050288254 Treating sepsis or septic shock by administering 1-stearoyl, 1-palmitoyl-, 1-myristoyl- lysophosphatidylcholine, or 1-oleoyllysophosphatidylcholine or sphingosylphosphorylcholine. |
| 12/29/2005 | US20050287642 Efficient protein expression system |
| 12/29/2005 | US20050287605 Caspase 3 inhibitors |
| 12/29/2005 | US20050287546 Novel proteases |
| 12/29/2005 | US20050287525 bioassay for testing peptides that bind to domain peptides of human immunodeficiency virus type I (HIV-1); peptides used for treating viral diseases |
| 12/29/2005 | US20050287174 Immunizing against HIV infection |
| 12/29/2005 | US20050287168 Recombinant spores |
| 12/29/2005 | US20050287165 Meningococcal antigens |
| 12/29/2005 | US20050287164 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections |